| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $199K | -2.2% |
| Cost of Revenue | $161K | -21.0% |
| Gross Profit | $38K | — |
| R&D Expense | $5.7M | +70.6% |
| SG&A Expense | $3.5M | +13.1% |
| Operating Income | -$10.4M | -41.0% |
| Net Income | -$10.0M | -38.5% |
| EPS (Basic) | -$1.61 | -37.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.5M | -48.2% |
| Accounts Receivable | $70K | +6.2% |
| Inventory | $81K | — |
| Current Assets | $9.1M | -46.1% |
| Total Assets | $12.2M | -36.9% |
| Current Liabilities | $931K | +107.2% |
| Total Liabilities | $2.2M | +46.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.1M | -11.7% |
| Capital Expenditures | $241K | +31.8% |
| Investing Cash Flow | -$523K | -67.2% |
| Financing Cash Flow | -$216K | -69.1% |
| Free Cash Flow | -$7.4M | -12.3% |
| Stockholders' Equity |
| $10.1M |
| -43.8% |